Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Real-world targeted treatment based on whole genome sequencing difficult in...

Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst...

Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer ( Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst, Australia )

Comment: Research developments stir hopes for melanoma

Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA

Comment: Research developments stir hopes for melanoma ( Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA )

New T cell–based immunotherapy shows promise for lethal stem cell transplant...

Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA )

Pembrolizumab found to be safe with durable responses in advanced non-small...

Dr Edward Garon - David Geffen School of Medicine at the University of...

Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )

PARP inhibitor combo shows early promise for patients with and without BRCA...

Dr Timothy Yap - Royal Marsden Hospital, London, UK

PARP inhibitor combo shows early promise for patients with and without BRCA mutations ( Dr Timothy Yap - Royal Marsden Hospital, London, UK )

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced...

Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma ( Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )

Long-term, regular aspirin use modestly decreased cancer risk

Prof Andrew Chan - Harvard Medical School and Massachusetts General Hospital...

Long-term, regular aspirin use modestly decreased cancer risk ( Prof Andrew Chan - Harvard Medical School and Massachusetts General Hospital, Boston USA )

Investigational ER degrader safe, with early signs of antitumour activity...

Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA

Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer ( Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA )

DNA stool test recommended as screening tool for colon cancer

Dr David Ahlquist - Mayo Clinic, Rochester, USA

DNA stool test recommended as screening tool for colon cancer ( Dr David Ahlquist - Mayo Clinic, Rochester, USA )

What are the objectives for CART-meso immunotherapy?

Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA

What are the objectives for CART-meso immunotherapy? ( Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA )

How will genomics be applied to patient therapy in future?

Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas

How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )

New T cell–based immunotherapy shows promise for lethal stem cell transplant...

Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )

More from ecancer